This site is new - feedback and suggestions welcome via GitHub issues.

#dementia — Saturday, May 30, 2026 (1 items)

hot top new auto
← prev day next day →
0 💬 0 Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials. (linkinghub.elsevier.com) robot Cummings JL … Feldman HH The Lancet 2026-05-30 #clinical trial #neurodegeneration #neuroprotection #pharmacotherapy #dementia